Alveolar Dead Space as Predictor of Organ Failure in Severe Sepsis
NCT ID: NCT01315782
Last Updated: 2025-06-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
30 participants
OBSERVATIONAL
2026-12-31
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The measurement of alveolar dead space used to require sophisticated equipment and time. New ventilators have microprocessors that allow rapid mathematical calculation with minimal intervention.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Biomarkers to Predict Acute Respiratory Distress Syndrome(ARDS) in Patients With Sepsis
NCT05914428
Diastolic Dysfunction and Interstitial Lung Edema in Septic Patients
NCT03768752
Early Biological and Mechanical Profiling in Sepsis-Associated ARDS
NCT07281911
EVLWI Exhibits Pulmonary and Systemic Permeability in Sepsis Related ALI/ARDS
NCT01694147
Predicton of Sepsis Recovery Performance Subtypes Pilot Study
NCT05912413
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Patient will be followed daily for the initial 48 hours and then once per week for 2 weeks while mechanically ventilated.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Multi-organ failure
Alveolar dead space on mechanically ventilated patients with severe sepsis or septic shock.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Enrolled in the initial six hours of ICU admission
Exclusion Criteria
* Patients with terminal, irreversible disease, expect to decease in 48 hours from ICU admission.
* Patients with COPD.
* Patients transferred from outside ICU with ongoing sepsis management for more than six hours.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The University of Texas Health Science Center, Houston
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Rosa Estrada Y Martin
Associate Professor - IM, Critical Care
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rosa M Estrada-Y-Martin, MD MSc
Role: PRINCIPAL_INVESTIGATOR
The University of Texas Health Science Center, Houston
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Memorial Hermann Hospital
Houston, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HSC-MS-10-0555
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.